87 related articles for article (PubMed ID: 23096201)
1. Insight into hepatocellular carcinoma biology with gadoxetate disodium-enhanced MRI.
Kagen A; Fowler K; Sirlin CB
Hepat Oncol; 2014 Jan; 1(1):95-105. PubMed ID: 30190944
[TBL] [Abstract][Full Text] [Related]
2. New understanding of hepatobiliary MRI.
Pastor CM; Vilgrain V
Nat Rev Gastroenterol Hepatol; 2024 Apr; ():. PubMed ID: 38565648
[No Abstract] [Full Text] [Related]
3. Added value of Gd-EOB-DTPA-enhanced Hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions.
Haimerl M; Wächtler M; Platzek I; Müller-Wille R; Niessen C; Hoffstetter P; Schreyer AG; Stroszczynski C; Wiggermann P
BMC Med Imaging; 2013 Dec; 13():41. PubMed ID: 24289722
[TBL] [Abstract][Full Text] [Related]
4. Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia.
Vanhooymissen IJSML; Thomeer MG; Braun LMM; Gest B; van Koeverden S; Willemssen FE; Hunink M; De Man RA; Ijzermans JN; Dwarkasing RS
J Magn Reson Imaging; 2019 Mar; 49(3):700-710. PubMed ID: 30252977
[TBL] [Abstract][Full Text] [Related]
5. A case study of glycogen storage disease type Ia presenting with multiple hepatocellular adenomas: an analysis by gadolinium ethoxybenzyl-diethylenetriamine-pentaacetic acid magnetic resonance imaging.
Li X; Jing H; Cheng L; Xia J; Wang J; Li Q; Liu C; Cai P
Quant Imaging Med Surg; 2021 Jun; 11(6):2785-2791. PubMed ID: 34079743
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte-specific contrast-enhanced MRI findings of focal nodular hyperplasia-like nodules in the liver following chemotherapy in pediatric cancer patients.
Özcan HN; Karçaaltıncaba M; Seber T; Yalçın B; Oğuz B; Akyüz C; Haliloğlu M
Diagn Interv Radiol; 2020 Jul; 26(4):370-376. PubMed ID: 32490830
[TBL] [Abstract][Full Text] [Related]
7. Patterns of enhancement in the hepatobiliary phase of gadoxetic acid-enhanced MRI.
Hui CL; Mautone M
Br J Radiol; 2020 Aug; 93(1112):20190989. PubMed ID: 32462892
[TBL] [Abstract][Full Text] [Related]
8. Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System.
Krishan S; Dhiman RK; Kalra N; Sharma R; Baijal SS; Arora A; Gulati A; Eapan A; Verma A; Keshava S; Mukund A; Deva S; Chaudhary R; Ganesan K; Taneja S; Gorsi U; Gamanagatti S; Madhusudan KS; Puri P; Shalimar ; Govil S; Wadhavan M; Saigal S; Kumar A; Thapar S; Duseja A; Saraf N; Khandelwal A; Mukhopadyay S; Gulati A; Shetty N; Verma N
J Clin Exp Hepatol; 2019; 9(5):625-651. PubMed ID: 31695253
[TBL] [Abstract][Full Text] [Related]
9. Hepatic changes after treatment with oxaliplatin.
Tenório LP; Miranda MFO; Andrade MQ; Araujo MAN
Radiol Bras; 2019; 52(5):343-344. PubMed ID: 31656355
[No Abstract] [Full Text] [Related]
10. Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma.
Kim MJ; Lee S; An C
Eur Radiol; 2019 Sep; 29(9):5101-5110. PubMed ID: 30788586
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in the Imaging Diagnosis of Hepatocellular Carcinoma: Value of Gadoxetic Acid-Enhanced MRI.
Joo I; Lee JM
Liver Cancer; 2016 Feb; 5(1):67-87. PubMed ID: 26989660
[TBL] [Abstract][Full Text] [Related]
12. Focal liver lesions: Practical magnetic resonance imaging approach.
Matos AP; Velloni F; Ramalho M; AlObaidy M; Rajapaksha A; Semelka RC
World J Hepatol; 2015 Aug; 7(16):1987-2008. PubMed ID: 26261689
[TBL] [Abstract][Full Text] [Related]
13. Gd-EOB-DTPA-Enhanced Magnetic Resonance Findings of a Giant Inflammatory Hepatocellular Adenoma: a Case Report and Review of the Literature.
Di Pietropaolo M; Briani C; Pilozzi E; Carbonetti F; David V; Iannicelli E
J Gastrointest Cancer; 2015 Dec; 46(4):421-5. PubMed ID: 25894634
[No Abstract] [Full Text] [Related]
14. Hypervascular benign and malignant liver tumors that require differentiation from hepatocellular carcinoma: key points of imaging diagnosis.
Murakami T; Tsurusaki M
Liver Cancer; 2014 May; 3(2):85-96. PubMed ID: 24944999
[TBL] [Abstract][Full Text] [Related]
15. Optimal timing and diagnostic adequacy of hepatocyte phase imaging with gadoxetate-enhanced liver MRI.
Bashir MR; Breault SR; Braun R; Do RK; Nelson RC; Reeder SB
Acad Radiol; 2014 Jun; 21(6):726-32. PubMed ID: 24717550
[TBL] [Abstract][Full Text] [Related]
16. Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience.
Grieser C; Steffen IG; Kramme IB; Bläker H; Kilic E; Perez Fernandez CM; Seehofer D; Schott E; Hamm B; Denecke T
Eur Radiol; 2014 Jun; 24(6):1339-48. PubMed ID: 24658870
[TBL] [Abstract][Full Text] [Related]
17. Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients.
Phongkitkarun S; Limsamutpetch K; Tannaphai P; Jatchavala J
World J Gastroenterol; 2013 Dec; 19(45):8357-65. PubMed ID: 24363528
[TBL] [Abstract][Full Text] [Related]
18. Solid liver masses: approach to management from the standpoint of a radiologist.
Garrett R
Curr Gastroenterol Rep; 2013 Dec; 15(12):359. PubMed ID: 24243519
[TBL] [Abstract][Full Text] [Related]
19. Hyperintense lesions on gadoxetate disodium-enhanced hepatobiliary phase imaging.
Kim MJ; Rhee HJ; Jeong HT
AJR Am J Roentgenol; 2012 Nov; 199(5):W575-86. PubMed ID: 23096201
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
